Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
Chong Gao(Nanjing Forestry University), Brian B. Haab(Van Andel Institute), Mirna Kheir Gouda(Cold Spring Harbor Laboratory), Ying Huang(Fred Hutch Cancer Center), Aatur D. Singhi(University of California, San Francisco), Ian Beddows(Van Andel Institute), Peter J. Allen(Memorial Sloan Kettering Cancer Center), Randall E. Brand(University of Pittsburgh), Susan Tsai(The Ohio State University Wexner Medical Center), Johnathan Hall(Van Andel Institute), Richard R. Drake(Medical University of South Carolina), Ben Staal(Van Andel Institute), Dennis Plenker(Cold Spring Harbor Laboratory), David A. Tuveson(Cold Spring Harbor Laboratory), Mohammed Aldakkak(Medical College of Wisconsin), Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Ying Liu(Chongqing University), Luke Wisniewski, Amer H. Zureikat(University of Pittsburgh Medical Center), Daniel Barnett(Van Andel Institute)
Cited by 30
Related Papers
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
|The Journal of Experimental Medicine|2017|2.4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Analysis of lung tumor initiation and progression using conditional expression of oncogenic <i>K-ras</i>
|Genes & Development|2001|2k
Restoration of p53 function leads to tumour regression in vivo
|Nature|2007|1.8k